CClinicalTrials.gg
CompletedNCT04919005Updated Jun 9, 2021

Virtual Environment to Aid Cognitive Stimulation of Elderly People With Early Alzheimer's

An interventional study of Virtual Environment in Alzheimer Disease, sponsored by University of Mogi das Cruzes. Completed at 1 site in Brazil. Open to participants aged 19 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-09.

Sponsored by University of Mogi das Cruzes · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 years 11 months after the study started (first participant enrolled Jul 2016, registered Jun 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Non-randomized
Ages
19 Years to 99 Years
Sex
All
01

Study summary

This research was carried out with the objective of verifying the possibility of intervention through cognitive training protocols to assist in the stimulation of neurons and to delay the degradation resulting from Alzheimer's disease in its initial phase. The specific objective of this research was to develop and validate a virtual environment of games (called SorrisoTur) that allows the intervention of cognitive training.

Read the detailed description

SorrisoTur encompasses cognitive training concepts and protocols in playful situations, which were coded in the form of 2D mini-games that are run on a computer connected to the Web, and designed to stimulate cognitive domains, such as memory, executive functions, spatial-visual skills, language (expression, comprehension, reading, and writing) and personality/behavior. For the comparison of results, three groups were created; one group of elderly people with Alzheimer's disease at an early stage, one group formed by healthy elderly, and another group with young people and applied Mini-Mental State Examination (MMSE) and Wechsler Intelligence Scale for Adults (WAIS-III) before and after of interventions with the games.

02

Conditions studied

  • Alzheimer Disease

Browse trials for

03

In context

Alzheimer Disease

3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.

This study's enrollment of 34 is below the median of 70 across 2,808 interventional studies indexed under Alzheimer Disease.

Browse Alzheimer Disease studies →

Lead sponsor

University of Mogi das Cruzes is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • People with physical or psychological conditions allow interacting with digital games;
  • Elderly over 60 years with mild Alzheimer;
  • Seniors over 60 Healthy;
  • Healthy Youth;

Exclusion criteria

Exclusion Criteria:

  • People without physical or psychological conditions allow interacting with digital games;
  • Elderly people over 60 years old who have any type of dementia other than Alzheimer, or moderate or severe Alzheimer;
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Healthy elderly people

    Twelve healthy elderly people. Each participant underwent a pre-test, the intervention with a Virtual Environment, and a post-test.

    Other: Virtual Environment

  • Experimental
    Elderly people with Alzheimer's in the initial phase

    Seven elderly people with Alzheimer's in the initial phase. Each participant underwent a pre-test, the intervention with a Virtual Environment, and a post-test.

    Other: Virtual Environment

  • Experimental
    Healthy young people

    Fifteen healthy young people. Each participant underwent a pre-test, the intervention with a Virtual Environment, and a post-test.

    Other: Virtual Environment

Interventions

  • OtherVirtual Environment

    The Virtual Environment was called SorrisoTur and consists of 10 mini-games with difficulty levels in a limited number of cities and mini-games distributed in a thematic scenario of the map of Brazil. The virtual environment consists of the cognitive training mini-games within a theme for all screens, mini-games, and information. The interventions with the Virtual Environment were administered in periods of one hour, twice a week, for a month.

06

What researchers measure

Primary outcomes

  1. Change on Wechsler Intelligence Scale for Adults (WAIS-III)

    The WAIS-III is an intellectual assessment that aims to analise the measures of the following Factorial Scales and Indexes: Verbal IQ (intelligence quotient), Execution IQ, Total IQ, Verbal Understanding Index, Perceptual Organization Indexes, Operational Memory Indexes and Processing speed index.

    Time frame: Baseline and after 4 weeks

  2. Change on Mini Mental State Examination (MMSE)

    The MMSE is a data collection instrument widely used in cases of dementia, it evaluates temporal and spatial orientation, short-term memory (immediate or attention) and skills of evocation, calculation, praxis, visuospatial, communication and language.

    Time frame: Baseline and after 4 weeks

07

Study locations

1 site
  • Terigi Augusto Scardovelli
    Mogi das Cruzes, São Paulo 08780-911, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04919005
Lead sponsor
University of Mogi das Cruzes
Responsible party
Terigi Augusto Scardovelli (Associate Professor, University of Mogi das Cruzes) — Principal investigator
First posted
Jun 9, 2021
Start date
Jul 1, 2016
Primary completion
Apr 30, 2017
Completion
Jul 20, 2017
Last update
Jun 9, 2021

Study contacts

Marcia A Bissaco, PhD
principal investigator · University of Mogi das Cruzes

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion